Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT03599609 : Central Nervous System Vascular Changes in Adult Sickle Cell Disease and the Effect of Treatment With Simvastatin
PhasePhase 1/Phase 2
AgesMin: 35 Years Max: N/A
Eligibility
Inclusion Criteria:

- Diagnosis of Sickle Cell Disease

Exclusion Criteria:

- Previous stroke

- Some relevant concomitant clinical condition (cancer, AIDS, inflammatory / autoimmune
diseases, etc.).

- Pregnancy

- Individuals considered to be vulnerable (minors,institutionalized individuals,
patients with a history of psychiatric illness with cognitive impairment or
incapacity)
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT03599609      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740